CDKN2A and adult T-cell leukemia/lymphoma: In total, 4/11 (36%) ATLL cases were positive for p16, while expression of this protein was noted in 3/20 (15%) cases in the PTCL-NOS group (Table 1 and Figure 3; p = 0.117).